CAR-T Cell Therapy for Solid Tumors: Are we Still That Far? a Systematic Review of Literature.
Auteurs : Karam A, Mjaess G, Martinez Chanza N, Aoun F, Bou Kheir G, Younes H, Kazzi H, Albisinni S, Roumeguère T Année : 2022 Journal : Cancer Invest
Prevalence and clinical impact of tumor BRCA1 and BRCA2 mutations in patients presenting with localized or metastatic hormone-sensitive prostate cancer.
Auteurs : Martinez Chanza N, Bernard B, Barthelemy P, Accarain A, Paesmans M, Desmyter L, Tkint de Roodenbeke D, Gil T, Sideris S, Roumeguere T, Hamid AA, Sweeney CJ Année : 2022 Journal : Prostate Cancer Prostatic Dis
Immune checkpoint inhibitors for BCG-resistant NMIBC: the dawn of a new era.